BioCardia CEO Peter Altman's Stock Purchase Amid Market Downturn
Peter Altman, President and CEO of BioCardia, Inc., recently acquired a block of the company's common stock. This insider transaction occurs while the stock is trading near its 52-week low. Separately, the company reported first-quarter 2026 earnings, detailing operational improvements and focusing on advancing its CardiAMP cell therapy program whi…